Association Between Higher Expression of YB-1 and Poor Prognosis in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma

References

• Li YX , YaoB , JinJet al. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J. Clin. Oncol. 24 , 181 – 189 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Huang MJ , JiangY , LiuWPet al. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract. Int. J. Radiat. Oncol. Biol. Phys. 70 , 166 – 174 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Armitage J , VoseJ , WeisenburgerD . International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.J. Clin. Oncol.26 , 4124 – 4130 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Bossard C , BelhadjK , ReyesFet al. Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a western series of 48 patients treated with first-line polychemotherapy within the Groupe d’Etude des Lymphomes de l’Adulte (GELA) trials. Blood 109 , 2183 – 2189 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Al-Hakeem DA , FedeleS , CarlosR , PorterS . Extranodal NK/T-cell lymphoma, nasal type.Oral Oncol.43 , 4 – 14 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Li YX , CouckePA , LiJYet al. Primary non-Hodgkin’s lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer 83 , 449 – 456 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Kim BS , KimDW , ImSAet al. Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone. Ann. Oncol. 20 , 121 – 128 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Zhang XX , XieCH , XuYet al. Salvage treatment improved survival of patients with relapsed extranodal natural killer/T-cell lymphoma, na-sal type. Int. J. Radiat. Oncol. Biol. Phys. 74 , 747 – 752 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Li YX , CouckePA , LiJYet al. Primary non-Hodgkin’s lymphoma of the nasal cavity: prognostic significance of paranasal extention and the role of radiotherapy and chemotherapy. Cancer 83 , 449 – 456 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Liang R , ToddD , ChanTKet al. Treatment outcome and prognostic factors for primary nansal lymphoma. J. Clin. Oncol. 13 , 666 – 670 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Yang Y , ZhangYJ , LinXB . Role of radiotherapy in the treatment of patients with early stage extranodal nasal-type NK/T-cell lymphoma and analysis of prognostic factors.Chin. J. Radiat. Oncol.18 , 285 – 289 ( 2009 ).
   Google Scholar
• Chim CS , MaSY , AuWYet al. Primary nasal natural killer cell lymphoma: long term treatment outcome and relationship with the International Prognostic Index. Blood 103 , 216 – 221 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Li CC , TienHF , TangJLet al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer 100 , 366 – 375 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Wang ZY , LiYX , WangWHet al. Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents. Blood 114 , 4771 – 4776 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Li YX , FangH , LiuQFet al. Clinical features and treatment outcome of nasal-typeNK/T-cell lymphoma of Waldeyer ring. Blood 112 , 3057 – 3064 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Li YX , LiuQF , FangHet al. Variable clinical presentations of nasal and Waldeyerring natural killer/T-cell lymphoma. Clin. Cancer Res. 15 , 2905 – 2912 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Wang ZY , LiYX , WangHet al. Unfavorable prognosis of elderly patients with early stage extranodal nasal-type NK/T-cell lymphoma. Ann. Oncol. 22 , 390 – 396 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lin TA , KongX , HaysteadTAet al. PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science 266 , 653 – 656 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Norman JT , LindahlGE , ShakibK , En-NiaA , YilmazE , MertensPR . The Y-box binding protein YB-1 suppresses collagen alpha 1(I) gene transcription via an evolutionarily conserved regulatory element in the proximal promoter.J. Biol. Chem.276 , 29880 – 29890 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Pisarev AV , SkabkinMA , ThomasAA , MerrickWC , OvchinnikovLP , ShatskyIN . Positive and negative effects of the major mammalian messenger ribonucleoprotein p50 on binding of 40S ribosomal subunits to the initiation codon of beta-globin mRNA.J. Biol. Chem.277 , 15445 – 15451 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Fukada T , TonksNK . Identification of YB-1 as a regulator of PTP1B expression: implications for regulation of insulin and cytokine signaling.EMBO J.22 , 479 – 493 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Kohno K , IzumiH , UchiumiT , AshizukaM , KuwanoM . The pleiotropic functions of the Y-box-binding protein, YB-1.Bioessays25 , 691 – 698 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Matsumoto K , WolffeAP . Gene regulation by Y-box proteins:coupling control of transcription and translation.Trends Cell Biol.8 , 318 – 323 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Shibahara K , SugioK , OsakiTet al. Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer. Clin. Cancer Res. 7 , 3151 – 3155 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Faury D , NantelA , DunnSEet al. Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors. J. Clin. Oncol. 25 , 1196 – 1208 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Stratford AL , HabibiG , AstaneheAet al. Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer providing a potential target for therapy. Breast Cancer Res. 9 , R61 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Gimenez-Bonafe P , FedorukMN , WhitmoreTGet al. YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity. Prostate 59 , 337 – 349 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Shibao K , TakanoH , NakayamaYet al. Enhanced coexpression of YB-1 and DNA topoisomerase II a genes in human colorectalcarcinomas. Int. J. Cancer 83 , 732 – 737 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Tay WL , YipGW , TanPHet al. Y-box-binding protein-1 is a promising predictive marker of radioresistance and chemoradioresistance in nasopharyngeal cancer. Mod. Pathol. 22 ( 2 ), 282 – 290 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Kashihara M , AzumaK , KawaharaAet al. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer. J. Thorac. Oncol. 4 , 1066 – 1074 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Hanzawa K , MomoseS , HigashiMet al. Y-box binding protein-1 expression in diffuse large B-cell lymphoma: an impact on prognosis in the rituximab era. Leuk. Lymphoma 51 ( 11 ), 2054 – 2062 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Li Y , WenZS , YangHXet al. High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma. Ann. Surg. Oncol. 18 ( 12 ), 3370 – 3376 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zhang Y , RengSR , WangLet al. Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy. Med. Oncol. 29 ( 3 ), 1992–1997 ( 2011 ).
   Web of Science ®Google Scholar
• Li YX , WangH , JinJet al. Radiotherapy alone with curative intent in patients with stage i extranodal nasal-type NK/T-cell lymphoma. Int. J. Radiat. Oncol. Biol. Phys. 82 ( 5 ), 1809 – 1815 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wang H , LiYX , WangWHet al. Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK/T-cell lymphoma. Int. J. Radiat. Oncol. Biol. Phys. 82 ( 3 ), 1115 – 1121 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Liu X , WangB , MaX , GuoY . NF-κB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.Jpn J. Clin. Oncol.39 ( 7 ), 418 – 424 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Kanemitsu N , IsobeY , MasudaAet al. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell lymphoma, nasal type (ENKL): Differences in biological and clinical behaviors of LMP1-positive and -negative ENKL. Clin. Cancer Res. 18 , 2164 – 2172 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Paik JH , JangJY , JeonYKet al. MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin. Cancer Res. 17 ( 14 ), 4761 – 4771 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Bargou RC , JürchottK , WagenerCet al. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat. Med. 3 ( 4 ), 447 – 450 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• McCarty KS , SzaboE , FlowersJLet al. Use of a monoclonal anti-estrogen receptor antibody in the inmunohistochemical evaluation of human tumors. Cancer Res. 46 , 4244 – 4248 ( 1986 ).
   PubMed Web of Science ®Google Scholar
• Ohga T , KoikeK , OnoMet al. Role of the human Y box-binding protein YB-1 in cellular sensitivity tothe DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res. 56 ( 18 ), 4224 – 4228 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Ohga T , UchiumiT , MakinoYet al. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance gene-1. J. Biol. Chem. 273 , 5997 – 6000 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Shibahara K , UchiumiT , FukudaTet al. Targeted disruption of one allele of theY-box binding protein-1 (YB-1) gene in mouse embryonic stem cells and increasedsensitivity to cisplatin and mitomycin C . Cancer Sci.95 ( 4 ), 348 – 353 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Stein U , BergmannS , SchefferGLet al. YB-1 facilitates basal and 5-fluorouracil-inducible expression of thehuman major vault protein (MVP) gene. Oncogene 24 , 3606 – 3618 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Stein U , JurchottK , WaltherW , BergmannS , SchlagPM , RoyerHD . Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads toenhanced expression of multidrug resistance-related ABC transporters.J. Biol. Chem.276 , 28562 – 28569 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Kim GE , ChoJH , YangWI , ChungEJ , SuhCO , ParkKR . Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment.J. Clin. Oncol.18 , 54 – 63 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Toulany M , SchickflußTA , EichelerW , KehlbachR , SchittekB , RodemannHP . Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation.Breast Cancer Res.13 , R28 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Woolley AG , AlgieM , SamuelWet al. Prognostic association of YB-1 expression in breast cancers: a matter of antibody. PLoS ONE 6 ( 6 ), e20603 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wachowiak R , ThieltgesS , RawnaqTet al. Y-box-binding protein-1 is a potential novel tumour marker for neuroblastoma. Anticancer Res. 30 , 1239 – 1242 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Di Costanzo A , TroianoA , di MartinoOet al. The p63 protein isoform ΔNp63α modulates Y-box binding protein 1 in its subcellular distribution and regulation of cell survival and motility genes. Biol. Chem. 287 , 30170 – 30180 ( 2012 ).
   Web of Science ®Google Scholar
• Toshiharu K , HideakiY , SatoshiA . Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma?Cancer11 , 2450 – 2454 ( 1999 ).
   Google Scholar
• Teruhiko F , AkihikoK , YujiBet al. Expression of HER2 and estrogen receptor α depends upon nuclear localization of Y-box binding protein-1 in human breast cancers. Cancer Res. 68 , 1504 – 1512 ( 2008 ).
   PubMed Web of Science ®Google Scholar